Atossa Therapeutics
ATOS
18 hedge funds and large institutions have $798K invested in Atossa Therapeutics in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
4,896% more capital inflows, than outflows
Capital inflows: $289K | Capital outflows: $5.79K
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
13% more funds holding
Funds holding: 16 → 18 (+2)
3.81% more ownership
Funds ownership: 10.05% → 13.86% (+3.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$73.9K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$49.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.2K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$45.4K |
| 5 |
Barclays
London,
United Kingdom
|
+$42.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Panagora Asset Management
Boston,
Massachusetts
|
-$3.13K |
| 2 |
Jane Street
New York
|
-$1.66K |
| 3 |
Advisor Group
Phoenix,
Arizona
|
-$1K |
ATOS Hedge Fund Activity: Q4 2018 in Review
18 of the 4,506 institutional investors tracked by Wall St. Rank reported a position in Atossa Therapeutics (ATOS) for Q4 2018, worth a combined $798K — down 19% from $991K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ATOS positions and 4 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, adding an estimated $73.9K. The largest seller was Panagora Asset Management, cutting an estimated $3.13K.
- 18 institutional investors held Atossa Therapeutics (ATOS) as of Q4 2018, up from 16 in Q3 2018.
- Funds reported $798K of Atossa Therapeutics stock for Q4 2018, down 19% quarter-over-quarter.
- 6 funds opened new Atossa Therapeutics positions in Q4 2018 and 4 closed out, a net change of +2 holders.
- The largest Atossa Therapeutics buyer in Q4 2018 was Virtu Financial, an estimated $73.9K added.
- The largest Atossa Therapeutics seller in Q4 2018 was Panagora Asset Management, an estimated $3.13K sold.
Based on aggregated 13F filings for Q4 2018.